Cytotoxic Function and Cytokine Production of Natural Killer Cells and Natural Killer T-Like Cells in Systemic Lupus Erythematosis Regulation with Interleukin-15

Table 1

Clinical characteristics of patients with systemic lupus erythematosis.

	Inactive SLE ()	Active SLE ()
Age (mean, range)	(28-69)	(12-68)
Disease duration (years)
SLEDAI (range)	0-6	7-25
C3 (mean ± SEM, mg/dL)
C4 (mean ± SEM, mg/dL)
Anti-ds DNA (mean ± SEM, mg/dL)
Malar rash (%)	29.2%	31.8%
Nephritis (%)	32.9%	51.6%
Arthritis (%)	71.8%	33.9%
Prednisolone (mg/day)
Azathioprine (%)	13.3%	30.0%
Mycophenolate mofetil (%)	5.0%	3.2%